These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11564163)

  • 41. The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome.
    Miyashiro D; Souza BCE; Torrealba MP; Manfrere KCG; Sato MN; Sanches JA
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas.
    Kołkowski K; Trzeciak M; Sokołowska-Wojdyło M
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ruxolitinib as a Novel Therapeutic Option for Poor Prognosis T-LBL Pediatric Patients.
    Veltri G; Silvestri C; Gallingani I; Sandei M; Vencato S; Lovisa F; Cortese G; Pillon M; Carraro E; Bresolin S; Biffi A; Basso G; Accordi B; Mussolin L; Serafin V
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma.
    Fujii K
    Front Oncol; 2018; 8():198. PubMed ID: 29915722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic activation profile of circulating CD8+ T cells in Sézary syndrome.
    Torrealba MP; Manfrere KC; Miyashiro DR; Lima JF; de M Oliveira L; Pereira NZ; Cury-Martins J; Pereira J; Duarte AJS; Sato MN; Sanches JA
    Oncotarget; 2018 Jan; 9(3):3497-3506. PubMed ID: 29423061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of the Functional Variant(s) that Explain the Low-Density Lipoprotein Receptor (LDLR) GWAS SNP rs6511720 Association with Lower LDL-C and Risk of CHD.
    Fairoozy RH; White J; Palmen J; Kalea AZ; Humphries SE
    PLoS One; 2016; 11(12):e0167676. PubMed ID: 27973560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover.
    Krejsgaard T; Lindahl LM; Mongan NP; Wasik MA; Litvinov IV; Iversen L; Langhoff E; Woetmann A; Odum N
    Semin Immunopathol; 2017 Apr; 39(3):269-282. PubMed ID: 27717961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T-cell-intrinsic Tif1α/Trim24 regulates IL-1R expression on TH2 cells and TH2 cell-mediated airway allergy.
    Perez-Lloret J; Okoye IS; Guidi R; Kannan Y; Coomes SM; Czieso S; Mengus G; Davidson I; Wilson MS
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):E568-76. PubMed ID: 26787865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma.
    Willerslev-Olsen A; Krejsgaard T; Lindahl LM; Litvinov IV; Fredholm S; Petersen DL; Nastasi C; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Bonefeld CM; Geisler C; Woetmann A; Iversen L; Kilian M; Koralov SB; Odum N
    Blood; 2016 Mar; 127(10):1287-96. PubMed ID: 26738536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of serum cytokines with colorectal polyp number and type in adult males.
    Comstock SS; Xu D; Hortos K; Kovan B; McCaskey S; Pathak DR; Fenton JI
    Eur J Cancer Prev; 2016 May; 25(3):173-81. PubMed ID: 25793917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiRNAs in primary cutaneous lymphomas.
    Yu X; Li Z; Liu J
    Cell Prolif; 2015 Jun; 48(3):271-7. PubMed ID: 25736784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines.
    Litvinov IV; Cordeiro B; Fredholm S; Ødum N; Zargham H; Huang Y; Zhou Y; Pehr K; Kupper TS; Woetmann A; Sasseville D
    Cell Cycle; 2014; 13(18):2975-82. PubMed ID: 25486484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression.
    Netchiporouk E; Litvinov IV; Moreau L; Gilbert M; Sasseville D; Duvic M
    Cell Cycle; 2014; 13(21):3331-5. PubMed ID: 25485578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.
    Kopp KL; Ralfkiaer U; Gjerdrum LM; Helvad R; Pedersen IH; Litman T; Jønson L; Hagedorn PH; Krejsgaard T; Gniadecki R; Bonefeld CM; Skov L; Geisler C; Wasik MA; Ralfkiaer E; Ødum N; Woetmann A
    Cell Cycle; 2013 Jun; 12(12):1939-47. PubMed ID: 23676217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphoma.
    Curiel-Lewandrowski C; Yamasaki H; Si CP; Jin X; Zhang Y; Richmond J; Tuzova M; Wilson K; Sullivan B; Jones D; Ryzhenko N; Little F; Kupper TS; Center DM; Cruikshank WW
    J Clin Invest; 2011 Dec; 121(12):4838-49. PubMed ID: 22080865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of the STAT6 transcription factor in Jurkat T-cells by the herpesvirus saimiri Tip protein.
    Kim Y; Kwon EK; Jeon JH; So I; Kim IG; Choi MS; Kim IS; Choi JK; Jung JU; Cho NH
    J Gen Virol; 2012 Feb; 93(Pt 2):330-340. PubMed ID: 22012462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-16 as a marker of Sézary syndrome onset and stage.
    Richmond J; Tuzova M; Parks A; Adams N; Martin E; Tawa M; Morrison L; Chaney K; Kupper TS; Curiel-Lewandrowski C; Cruikshank W
    J Clin Immunol; 2011 Feb; 31(1):39-50. PubMed ID: 20878214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A mouse model for the Sézary syndrome.
    Doebbeling U
    J Exp Clin Cancer Res; 2010 Feb; 29(1):11. PubMed ID: 20149229
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebral microvascular IL15 is a novel mediator of TNF action.
    Pan W; Yu C; Hsuchou H; Khan RS; Kastin AJ
    J Neurochem; 2009 Nov; 111(3):819-27. PubMed ID: 19719822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin-7 stimulates secretion of S100A4 by activating the JAK/STAT signaling pathway in human articular chondrocytes.
    Yammani RR; Long D; Loeser RF
    Arthritis Rheum; 2009 Mar; 60(3):792-800. PubMed ID: 19248116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.